The International Trade Administration published notices in the Feb. 1 Federal Register on the following AD/CV proceedings (any notices that announce changes to AD/CV duty rates, scope, affected firms, or effective dates will be detailed in another ITT article):
The International Trade Commission is publishing notices in the Jan.31 Federal Register on the following AD/CV injury, Section 337 patent, and other trade proceedings (any notices that warrant a more detailed summary will appear in another ITT article):
Neptune Technologies & Bioresources and its subsidiary Acasti Pharma filed a Section 337 complaint at the International Trade Commission Jan. 29, alleging that ten companies are importing and selling omega-3 extracts that infringe its patents. The products at issue are extracts of omega-3 fatty acids from Antarctic krill. Neptune says the ten companies are infringing on its patents related to the extraction and purification process of the “krill oil.” The company is requesting limited exclusion and cease and desist orders against all respondents. The complaint proposed the following as respondents:
The International Trade Commission is asking for comments by about Feb. 9 on public interest factors that it should take into consideration in the Section 337 patent investigation of certain fluorescent reflector lamps and products and components containing same. Neptun requested the investigation, alleging that Maxlite, Technical Consumer Products, Salco Products, and Litetronics International are importing reflector lamps from China that infringe Neptun’s patents, and selling them in the U.S. Neptun is asking for limited exclusion and cease and desist orders.
The International Trade Administration is giving advance notice that it and the International Trade Commission will consider revoking the antidumping duty order on persulfates from China (A-570-847) in their automatic five-year sunset reviews scheduled to begin in March. Advance notice is given because automatic sunset reviews have short deadlines. An order will be revoked unless the ITA finds that revocation would lead to a continuation or recurrence of dumping and the ITC finds that revocation would result in continuation or recurrence of material injury to a U.S. industry. As a result, a negative determination by either the ITA or the ITC would result in the revocation of the order.
The International Trade Administration announced the opportunity to request administrative reviews by Feb. 28 for producers and exporters subject to 22 antidumping duty orders and four countervailing duty orders with February anniversary dates. Affected products include frozen warmwater shrimp, preserved mushrooms, pipe fittings, etc.
The International Trade Administration and the International Trade Commission initiated the five-year Sunset Review of the antidumping duty order on sodium hexametaphosphate from China (A-570-908).
The International Trade Administration issued the preliminary results of its antidumping administrative review of stainless steel bar from India (A-533-810) for Ambica Steels Limited. The ITA calculated a preliminary zero AD rate for the company. It also rescinded this review with respect to Mukand, Ltd. because of a withdrawal of requests for review. If the ITA continues to find a zero AD rate for Ambica in the final results, it will instruct CBP to liquidate entries of Ambica's subject merchandise during the period of review without regard to AD duties. These preliminary results are not in effect. The ITA may modify them in the final results of this review and change the estimated AD cash deposit rate for this company.
The International Trade Commission is publishing notices in the Jan.30 Federal Register on the following AD/CV injury, Section 337 patent, and other trade proceedings (any notices that warrant a more detailed summary will appear in another ITT article):
The International Trade Commission is asking for comments by Feb. 28 on public interest factors it should take into consideration in its review of an administrative law judge’s determination in the Section 337 patent investigation of certain kinesiotherapy devices and components thereof (337-TA-823). The ITC is considering issuing an exclusion order against devices that infringe Standard Innovation Corporation’s patents.